Literature DB >> 16688216

Induction of apoptosis limits cytomegalovirus cross-species infection.

Igor Jurak1, Wolfram Brune.   

Abstract

Cross-species infections are responsible for the majority of emerging and re-emerging viral diseases. However, little is known about the mechanisms that restrict viruses to a certain host species, and the factors viruses need to cross the species barrier and replicate in a different host. Cytomegaloviruses (CMVs) are representatives of the beta-herpesviruses that are highly species specific. They replicate only in cells of their own or a closely related species. In this study, the molecular mechanism underlying the cytomegalovirus species specificity was investigated. We show that infection of human cells with the murine cytomegalovirus (MCMV) triggers the intrinsic apoptosis pathway involving caspase-9 activation. MCMV can break the species barrier and replicate in human cells if apoptosis is blocked by Bcl-2 or a functionally analogous protein. A single gene of the human cytomegalovirus encoding a mitochondrial inhibitor of apoptosis is sufficient to allow MCMV replication in human cells. Moreover, the same principle facilitates replication of the rat cytomegalovirus in human cells. Thus, induction of apoptosis serves as an innate immune defense to inhibit cross-species infections of rodent CMVs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16688216      PMCID: PMC1478185          DOI: 10.1038/sj.emboj.7601133

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  67 in total

Review 1.  Caspase inhibitors.

Authors:  P G Ekert; J Silke; D L Vaux
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

Review 2.  Forward with BACs: new tools for herpesvirus genomics.

Authors:  W Brune; M Messerle; U H Koszinowski
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

3.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

Review 4.  Cross-species infections.

Authors:  R A Weiss
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

Review 5.  Insights into the mechanisms of CMV-mediated interference with cellular apoptosis.

Authors:  Christopher E Andoniou; Mariapia A Degli-Esposti
Journal:  Immunol Cell Biol       Date:  2006-02       Impact factor: 5.126

Review 6.  AIDS as a zoonosis: scientific and public health implications.

Authors:  B H Hahn; G M Shaw; K M De Cock; P M Sharp
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

7.  Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein.

Authors:  Wolfram Brune; Michael Nevels; Thomas Shenk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 8.  Bcl-2-family proteins and the role of mitochondria in apoptosis.

Authors:  Tomomi Kuwana; Donald D Newmeyer
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

9.  Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.

Authors:  Markus Altmann; Wolfgang Hammerschmidt
Journal:  PLoS Biol       Date:  2005-11-15       Impact factor: 8.029

Review 10.  DNA-damage response pathways triggered by viral replication.

Authors:  Alison Sinclair; Sarah Yarranton; Celine Schelcher
Journal:  Expert Rev Mol Med       Date:  2006-03-03       Impact factor: 5.600

View more
  62 in total

1.  Trafficking of UL37 proteins into mitochondrion-associated membranes during permissive human cytomegalovirus infection.

Authors:  Petros Bozidis; Chad D Williamson; Daniel S Wong; Anamaris M Colberg-Poley
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Species specificity of protein kinase r antagonism by cytomegalovirus TRS1 genes.

Authors:  Stephanie J Child; Greg Brennan; Jacquelyn E Braggin; Adam P Geballe
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein.

Authors:  Claudia Mack; Albert Sickmann; David Lembo; Wolfram Brune
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 4.  Virion factors that target Daxx to overcome intrinsic immunity.

Authors:  Sabrina Schreiner; Harald Wodrich
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

5.  Functional Dissection of an Alternatively Spliced Herpesvirus Gene by Splice Site Mutagenesis.

Authors:  Tim Schommartz; Stefan Loroch; Malik Alawi; Adam Grundhoff; Albert Sickmann; Wolfram Brune
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability.

Authors:  Jiajia Tang; Giada Frascaroli; Robert J Lebbink; Eleonore Ostermann; Wolfram Brune
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

7.  Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins.

Authors:  Kristi L Norris; Richard J Youle
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

8.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

9.  Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells.

Authors:  Lüder Wiebusch; Anke Neuwirth; Linus Grabenhenrich; Sebastian Voigt; Christian Hagemeier
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress.

Authors:  Natalia I Reim; Jeremy P Kamil; Depeng Wang; Alison Lin; Mayuri Sharma; Maria Ericsson; Jean M Pesola; David E Golan; Donald M Coen
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.